Tapewire

Nasdaq · USD

PRCT

PROCEPT BioRobotics Corp

Export transactions ↓
Tapewire entity
4831
SEC CIK
0001588978
Parsed reports
198

Last 12 months

Inside the activity.

8 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202678
Apr 202600
May 202600
Jun 202603
Jul 202600
Aug 202610
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 04, 2025 Filed Jun 6, 2025 00:05 UTC SaleCommon Stock 8,600 $61.40 $528,052.04
Disclosure

SEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 7

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 114,363

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.13 to $61.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 00:05 UTC SaleCommon Stock 16,400 $60.82 $997,503.76
Disclosure

SEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 6

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 122,963

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.13 to $61.125, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
June 03, 2025 Filed Jun 6, 2025 00:05 UTC SaleCommon Stock 1,518 $61.83 $93,855.97
Disclosure

SEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 5

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 139,363

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.74 to $61.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
June 03, 2025 Filed Jun 6, 2025 00:05 UTC SaleCommon Stock 11,602 $61.22 $710,228.03
Disclosure

SEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 4

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 140,881

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.74 to $61.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
June 03, 2025 Filed Jun 6, 2025 00:05 UTC SaleCommon Stock 9,880 $60.23 $595,094.14
Disclosure

SEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 3

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 152,483

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.74 to $60.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
June 03, 2025 Filed Jun 6, 2025 00:05 UTC SaleCommon Stock 1,100 $59.14 $65,058.95
Disclosure

SEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 2

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 162,363

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.73 to $59.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
June 03, 2025 Filed Jun 6, 2025 00:05 UTC SaleCommon Stock 900 $58.04 $52,237.89
Disclosure

SEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 1

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 163,463

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.65 to $58.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
May 09, 2025 Filed May 13, 2025 20:59 UTC
Zadno RezaDirector · President, CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 13,759 $0.00 Strike: $7.27 $0.00
Disclosure

SEC source: 0001628280-25-025179 · wk-form4_1747169964.xml · derivative · entry 2

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,871

Underlying: Common Stock · 13,759 shares

Expires 2031-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The Stock option was granted on June 22, 2021 and vests 25% on the six month anniversary of the grant date and the remainder vests on each monthly anniversary over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.

Read SEC document
May 09, 2025 Filed May 13, 2025 20:59 UTC
Zadno RezaDirector · President, CEO
Exercise / conversionCommon Stock 13,759 $7.27 $100,027.93
Disclosure

SEC source: 0001628280-25-025179 · wk-form4_1747169964.xml · nonDerivative · entry 1

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,829

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 18, 2025 Filed Mar 19, 2025 20:16 UTC
Zadno RezaDirector · President, CEO
SaleCommon Stock 5,475 $57.06 $312,403.50
Disclosure

SEC source: 0001628280-25-013832 · wk-form4_1742415395.xml · nonDerivative · entry 1

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,070

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.

F2 · price: The price reported in Column 4 is a weighted average price.

Read SEC document
March 18, 2025 Filed Mar 19, 2025 20:04 UTC
Nouri AlalehEVP, CLO, CORP. SEC.
SaleCommon Stock 316 $57.06 $18,030.96
Disclosure

SEC source: 0001628280-25-013813 · wk-form4_1742414660.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,473

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.

F2 · price: The price reported in Column 4 is a weighted average price.

Read SEC document
March 18, 2025 Filed Mar 19, 2025 20:15 UTC
Waters KevinEVP, CFO
SaleCommon Stock 733 $57.06 $41,824.98
Disclosure

SEC source: 0001628280-25-013830 · wk-form4_1742415331.xml · nonDerivative · entry 1

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,991

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.

F2 · price: The price reported in Column 4 is a weighted average price.

Read SEC document
March 18, 2025 Filed Mar 19, 2025 20:08 UTC
Shiblaq HishamEVP, Chief Comm. Officer
SaleCommon Stock 247 $57.06 $14,093.82
Disclosure

SEC source: 0001628280-25-013817 · wk-form4_1742414903.xml · nonDerivative · entry 1

Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,133

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.

F2 · price: The price reported in Column 4 is a weighted average price.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 20:26 UTC
Zadno RezaDirector · President, CEO
SaleCommon Stock 15,916 $61.31 $975,809.96
Disclosure

SEC source: 0001628280-25-011700 · wk-form4_1741638404.xml · nonDerivative · entry 1

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,545

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.

F2 · price: The price reported in Column 4 is a weighted average price.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 20:31 UTC
Nouri AlalehEVP, CLO, CORP. SEC.
SaleCommon Stock 3,641 $61.31 $223,229.71
Disclosure

SEC source: 0001628280-25-011710 · wk-form4_1741638660.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,789

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.

F2 · price: The price reported in Column 4 is a weighted average price.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 20:29 UTC
Shiblaq HishamEVP, Chief Comm. Officer
SaleCommon Stock 3,588 $61.31 $219,980.28
Disclosure

SEC source: 0001628280-25-011707 · wk-form4_1741638582.xml · nonDerivative · entry 1

Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,380

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.

F2 · price: The price reported in Column 4 is a weighted average price.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 20:28 UTC
Waters KevinEVP, CFO
SaleCommon Stock 3,662 $61.31 $224,517.22
Disclosure

SEC source: 0001628280-25-011703 · wk-form4_1741638492.xml · nonDerivative · entry 1

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,724

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.

F2 · price: The price reported in Column 4 is a weighted average price.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:30 UTC
Zadno RezaDirector · President, CEO
GrantStock Option (Right to Buy) · Derivative 36,831 $0.00 Strike: $60.60 $0.00
Disclosure

SEC source: 0001628280-25-010596 · wk-form4_1741213805.xml · derivative · entry 2

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,831

Underlying: Common Stock · 36,831 shares

Expires 2035-03-02

F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025 over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:30 UTC
Zadno RezaDirector · President, CEO
GrantCommon Stock 41,699 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-010596 · wk-form4_1741213805.xml · nonDerivative · entry 1

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,461

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2026, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:36 UTC
Nouri AlalehEVP, CLO, CORP. SEC.
GrantStock Option (Right to Buy) · Derivative 11,445 $0.00 Strike: $60.60 $0.00
Disclosure

SEC source: 0001628280-25-010628 · wk-form4_1741214157.xml · derivative · entry 2

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,445

Underlying: Common Stock · 11,445 shares

Expires 2035-03-02

F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:36 UTC
Nouri AlalehEVP, CLO, CORP. SEC.
GrantCommon Stock 12,958 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-010628 · wk-form4_1741214157.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,430

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2026, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:34 UTC
Shiblaq HishamEVP, Chief Comm. Officer
GrantStock Option (Right to Buy) · Derivative 9,810 $0.00 Strike: $60.60 $0.00
Disclosure

SEC source: 0001628280-25-010616 · wk-form4_1741214062.xml · derivative · entry 2

Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,810

Underlying: Common Stock · 9,810 shares

Expires 2035-03-02

F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:34 UTC
Shiblaq HishamEVP, Chief Comm. Officer
GrantCommon Stock 11,107 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-010616 · wk-form4_1741214062.xml · nonDerivative · entry 1

Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,968

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2026, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:32 UTC
Waters KevinEVP, CFO
GrantStock Option (Right to Buy) · Derivative 14,388 $0.00 Strike: $60.60 $0.00
Disclosure

SEC source: 0001628280-25-010602 · wk-form4_1741213906.xml · derivative · entry 2

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,388

Underlying: Common Stock · 14,388 shares

Expires 2035-03-02

F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:32 UTC
Waters KevinEVP, CFO
GrantCommon Stock 16,290 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-010602 · wk-form4_1741213906.xml · nonDerivative · entry 1

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,386

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2026, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:39 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,263 $0.00 Strike: $0.86 $0.00
Disclosure

SEC source: 0001628280-25-005209 · wk-form4_1739399980.xml · derivative · entry 4

MOLL FREDERIC H · CIK 0001260157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,263 shares

Expires 2025-02-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Stock option is fully vested and exercisable.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:39 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 26,749 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001628280-25-005209 · wk-form4_1739399980.xml · derivative · entry 3

MOLL FREDERIC H · CIK 0001260157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,749 shares

Expires 2025-09-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Stock option is fully vested and exercisable.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:39 UTC Exercise / conversionCommon Stock 5,263 $0.86 $4,526.18
Disclosure

SEC source: 0001628280-25-005209 · wk-form4_1739399980.xml · nonDerivative · entry 2

MOLL FREDERIC H · CIK 0001260157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 841,621

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:39 UTC Exercise / conversionCommon Stock 26,749 $1.33 $35,576.17
Disclosure

SEC source: 0001628280-25-005209 · wk-form4_1739399980.xml · nonDerivative · entry 1

MOLL FREDERIC H · CIK 0001260157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 836,358

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:20 UTC
Zadno RezaDirector · President, CEO
SaleCommon Stock 2,235 $99.04 $221,359.32
Disclosure

SEC source: 0001628280-24-050224 · wk-form4_1733520032.xml · nonDerivative · entry 4

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 152,762

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.97 to $99.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:20 UTC
Zadno RezaDirector · President, CEO
SaleCommon Stock 5,126 $98.09 $502,807.80
Disclosure

SEC source: 0001628280-24-050224 · wk-form4_1733520032.xml · nonDerivative · entry 3

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 154,997

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.66 to $98.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:20 UTC
Zadno RezaDirector · President, CEO
SaleCommon Stock 13,762 $97.01 $1,335,065.38
Disclosure

SEC source: 0001628280-24-050224 · wk-form4_1733520032.xml · nonDerivative · entry 2

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,123

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.65 to $97.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:20 UTC
Zadno RezaDirector · President, CEO
SaleCommon Stock 5,300 $96.15 $509,611.96
Disclosure

SEC source: 0001628280-24-050224 · wk-form4_1733520032.xml · nonDerivative · entry 1

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 173,885

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.65 to $96.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:17 UTC
Nouri AlalehEVP, CLO, CORP. SEC.
Exercise / conversionStock Option (Right to Buy) · Derivative 12,092 $0.00 Strike: $37.02 $0.00
Disclosure

SEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · derivative · entry 9

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,094

Underlying: Common Stock · 12,092 shares

Expires 2033-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The Stock option was granted on March 5, 2023 and vests 1/48th of the shares monthly from the vesting commencement date of March 5, 2023 over a four year period thereafter, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:17 UTC
Nouri AlalehEVP, CLO, CORP. SEC.
Exercise / conversionStock Option (Right to Buy) · Derivative 4,162 $0.00 Strike: $34.99 $0.00
Disclosure

SEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · derivative · entry 8

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,728

Underlying: Common Stock · 4,162 shares

Expires 2032-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The Stock option was granted on March 31, 2022 and vested 1/48th on the anniversary of the vesting commencement date of March 15, 2022, and vesting monthly over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:17 UTC
Nouri AlalehEVP, CLO, CORP. SEC.
Exercise / conversionStock Option (Right to Buy) · Derivative 11,838 $0.00 Strike: $7.27 $0.00
Disclosure

SEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · derivative · entry 7

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,056

Underlying: Common Stock · 11,838 shares

Expires 2031-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The Stock option was granted on June 22, 2021 and vested over a four year period.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:17 UTC
Nouri AlalehEVP, CLO, CORP. SEC.
SaleCommon Stock 8,118 $97.90 $794,752.20
Disclosure

SEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 6

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,472

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 3, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.58 to $98.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:17 UTC
Nouri AlalehEVP, CLO, CORP. SEC.
SaleCommon Stock 16,187 $96.98 $1,569,815.26
Disclosure

SEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 5

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,590

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 3, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.56 to $97.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:17 UTC
Nouri AlalehEVP, CLO, CORP. SEC.
SaleCommon Stock 3,787 $96.12 $364,006.44
Disclosure

SEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 4

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,777

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 3, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.55 to $96.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:17 UTC
Nouri AlalehEVP, CLO, CORP. SEC.
Exercise / conversionCommon Stock 12,092 $37.02 $447,645.84
Disclosure

SEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 3

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,564

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:17 UTC
Nouri AlalehEVP, CLO, CORP. SEC.
Exercise / conversionCommon Stock 4,162 $34.99 $145,628.38
Disclosure

SEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 2

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,472

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:17 UTC
Nouri AlalehEVP, CLO, CORP. SEC.
Exercise / conversionCommon Stock 11,838 $7.27 $86,062.26
Disclosure

SEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,310

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 27, 2024 Filed Dec 2, 2024 21:12 UTC
Zadno RezaDirector · President, CEO
SaleCommon Stock 1,403 $99.96 $140,244.02
Disclosure

SEC source: 0001628280-24-049561 · wk-form4_1733173968.xml · nonDerivative · entry 4

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 179,185

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.77 to $100.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
November 27, 2024 Filed Dec 2, 2024 21:12 UTC
Zadno RezaDirector · President, CEO
SaleCommon Stock 5,189 $99.24 $514,941.31
Disclosure

SEC source: 0001628280-24-049561 · wk-form4_1733173968.xml · nonDerivative · entry 3

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 180,588

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.75 to $99.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
November 27, 2024 Filed Dec 2, 2024 21:12 UTC
Zadno RezaDirector · President, CEO
SaleCommon Stock 1,684 $98.00 $165,033.85
Disclosure

SEC source: 0001628280-24-049561 · wk-form4_1733173968.xml · nonDerivative · entry 2

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 185,777

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.74 to $98.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
November 27, 2024 Filed Dec 2, 2024 21:12 UTC
Zadno RezaDirector · President, CEO
SaleCommon Stock 18,144 $97.25 $1,764,418.72
Disclosure

SEC source: 0001628280-24-049561 · wk-form4_1733173968.xml · nonDerivative · entry 1

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,461

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.74 to $97.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 21:07 UTC
Zadno RezaDirector · President, CEO
SaleCommon Stock 500 $93.88 $46,942.00
Disclosure

SEC source: 0001628280-24-048972 · wk-form4_1732309658.xml · nonDerivative · entry 3

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 205,605

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.62 to $94.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 21:07 UTC
Zadno RezaDirector · President, CEO
SaleCommon Stock 15,809 $92.82 $1,467,350.28
Disclosure

SEC source: 0001628280-24-048972 · wk-form4_1732309658.xml · nonDerivative · entry 2

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 206,105

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.51 to $93.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 21:07 UTC
Zadno RezaDirector · President, CEO
SaleCommon Stock 10,111 $92.12 $931,431.39
Disclosure

SEC source: 0001628280-24-048972 · wk-form4_1732309658.xml · nonDerivative · entry 1

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 221,914

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.51 to $92.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
November 13, 2024 Filed Nov 15, 2024 21:28 UTC
Zadno RezaDirector · President, CEO
SaleCommon Stock 4,510 $95.58 $431,074.37
Disclosure

SEC source: 0001628280-24-048105 · wk-form4_1731706118.xml · nonDerivative · entry 4

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 232,025

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.31 to $96.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.